Clinical Trial
doi: 10.3899/jrheum.101256.
Minimal important difference and responsiveness to change of the SF-36 in patients with psoriatic arthritis receiving tumor necrosis factor-α blockers
- PMID: 21885524
- DOI: 10.3899/jrheum.101256
Item in Clipboard
Clinical Trial
Minimal important difference and responsiveness to change of the SF-36 in patients with psoriatic arthritis receiving tumor necrosis factor-α blockers
J Rheumatol.
2011 Sep.
No abstract available
Similar articles
-
Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry.Arthritis Rheum. 2011 Feb;63(2):382-90. doi: 10.1002/art.30117. Arthritis Rheum. 2011. PMID: 21279995
-
Time and predictors of response to tumour necrosis factor-alpha blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort.Rheumatology (Oxford). 2010 Jul;49(7):1361-6. doi: 10.1093/rheumatology/keq091. Epub 2010 Apr 12. Rheumatology (Oxford). 2010. PMID: 20385615
-
Update on psoriatic arthritis.Int J Dermatol. 2004 Jul;43(7):479-81. doi: 10.1111/j.1365-4632.2004.02407.x. Int J Dermatol. 2004. PMID: 15230883 No abstract available.
-
Psoriatic arthritis.Dermatol Ther. 2010 Mar-Apr;23(2):123-36. doi: 10.1111/j.1529-8019.2010.01306.x. Dermatol Ther. 2010. PMID: 20415819 Review.
-
TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis.Intern Emerg Med. 2012 Sep;7 Suppl 2:S97-8. doi: 10.1007/s11739-011-0704-6. Epub 2011 Oct 1. Intern Emerg Med. 2012. PMID: 21964813 Review. No abstract available.
Cited by
-
Predictors of functional deterioration in Chinese patients with psoriatic arthritis: a longitudinal study.BMC Musculoskelet Disord. 2014 Aug 26;15:284. doi: 10.1186/1471-2474-15-284. BMC Musculoskelet Disord. 2014. PMID: 25160684 Free PMC article.
-
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination.RMD Open. 2021 Jan;7(1):e001484. doi: 10.1136/rmdopen-2020-001484. RMD Open. 2021. PMID: 33452180 Free PMC article. Clinical Trial.
-
Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis.Cochrane Database Syst Rev. 2025 Feb 13;2(2):CD013614. doi: 10.1002/14651858.CD013614.pub2. Cochrane Database Syst Rev. 2025. PMID: 39945386
-
A comparison of physical function instruments in psoriatic arthritis: HAQ-DI vs MDHAQ vs PROMIS10 global physical health.Rheumatology (Oxford). 2021 May 14;60(5):2307-2316. doi: 10.1093/rheumatology/keaa591. Rheumatology (Oxford). 2021. PMID: 33313838 Free PMC article.
-
Patient-Reported Outcomes in Psoriatic Arthritis.Rheum Dis Clin North Am. 2016 May;42(2):265-83. doi: 10.1016/j.rdc.2016.01.002. Epub 2016 Mar 16. Rheum Dis Clin North Am. 2016. PMID: 27133489 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
